Sign in
6-K

Report of Foreign Issuer

TRINITY BIOTECH PLC Filed Acc 0001554855-26-001482

Contact: Trinity Biotech plc Gary Keating, PhD. (353)-1-2769800 RedChip Companies Inc. Dave Gentry, CEO (1)-407-644-4256 (1)-800-RED-CHIP (733-2447) [email protected]

  • New Trinity Biotech Clinical Trial Data Shows Its CGM+ Technology Tackles a Major CGM User Problem by Going Beyond Glucose-Only Monitoring

From the SEC's structured data for this filing